|
Trial no.:
|
PACTR202607535790876 |
Date of Registration:
|
22/07/2026 |
|
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
| TRIAL DESCRIPTION |
|
Public title
|
Efficacy of Locally Delivered Black Seed Oil Gel (Nigella Sativa) as an Adjunctive To Non-Surgical Treatment in Stage II Grade B Periodontitis Patients: A Randomized Controlled Clinical Trial |
| Official scientific title |
Efficacy of Locally Delivered Black Seed Oil Gel (Nigella Sativa) as an Adjunctive To Non-Surgical Treatment in Stage II Grade B Periodontitis Patients: A Randomized Controlled Clinical Trial |
|
Brief summary describing the background
and objectives of the trial
|
Periodontitis is a chronic inflammatory disease associated with a dysbiotic subgingival biofilm and progressive destruction of the tooth-supporting tissues. Scaling and root planing is the standard nonsurgical periodontal treatment; however, mechanical debridement alone may not completely eliminate periodontal pathogens or adequately control inflammation. Consequently, locally delivered antimicrobial agents have been proposed as adjuncts to improve periodontal treatment outcomes while reducing the adverse effects associated with systemic medications.
*Nigella sativa* (black seed) contains biologically active constituents, particularly thymoquinone, with reported antimicrobial, anti-inflammatory, and antioxidant properties. These properties may support its use as a locally delivered adjunctive treatment for periodontitis.
The objective of this randomized controlled clinical trial is to evaluate the clinical and microbiological efficacy of locally delivered *Nigella sativa* oil gel as an adjunct to scaling and root planing in patients with Stage II, Grade B periodontitis. The intervention will be compared with scaling and root planing combined with a placebo gel. Clinical outcomes will include probing pocket depth, clinical attachment level, bleeding on probing, and gingival index. Microbiological efficacy will be assessed by measuring *Porphyromonas gingivalis* levels using quantitative polymerase chain reaction.
|
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Oral Health |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Drugs |
| Anticipated trial start date |
01/03/2025 |
| Actual trial start date |
20/03/2025 |
| Anticipated date of last follow up |
20/09/2025 |
| Actual Last follow-up date |
20/12/2025 |
| Anticipated target sample size (number of participants) |
30 |
| Actual target sample size (number of participants) |
30 |
| Recruitment status |
Completed |
| Publication URL |
|
|